From the Departments of Molecular Microbiology and Immunology and.
J Biol Chem. 2014 Mar 28;289(13):8799-809. doi: 10.1074/jbc.M113.546960. Epub 2014 Feb 4.
Equilibrative nucleoside transporters of the SLC29 family play important roles in many physiological and pharmacological processes, including import of drugs for treatment of cancer, AIDS, cardiovascular, and parasitic diseases. However, no crystal structure is available for any member of this family. In previous studies we generated a computational model of the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1) that captured this permease in the outward-closed conformation, and we identified the extracellular gate. In the present study we have modeled the inward-closed conformation of LdNT1.1 using the crystal structure of the Escherichia coli fucose transporter FucP and have identified four transmembrane helices whose ends close to form a predicted intracellular gate. We have tested this prediction by site-directed mutagenesis of relevant helix residues and by cross-linking of introduced cysteine pairs. The results are consistent with the predictions of the computational model and suggest that a similarly constituted gate operates in other members of the equilibrative nucleoside transporter family.
SLC29 家族的平衡核苷转运体在许多生理和药理过程中发挥着重要作用,包括用于治疗癌症、艾滋病、心血管和寄生虫疾病的药物的摄取。然而,该家族的任何成员都没有晶体结构。在之前的研究中,我们生成了利什曼原虫核苷转运蛋白 1.1(LdNT1.1)的计算模型,该模型捕获了这种易化转运蛋白的外向闭合构象,并确定了细胞外门。在本研究中,我们使用大肠杆菌果糖转运蛋白 FucP 的晶体结构对 LdNT1.1 的内向闭合构象进行了建模,并鉴定了四个跨膜螺旋,其末端靠近形成预测的细胞内门。我们通过相关螺旋残基的定点突变和引入的半胱氨酸对的交联来测试这一预测。结果与计算模型的预测一致,并表明在其他易化核苷转运体家族成员中也存在类似的门控结构。